Ascelia Pharma AB (publ)

kr 0.56As of Sun 8 Nov 2026, 12:00 UTC
STO:ACEHealthcare
Country Sweden
PE (Fwd) •••
TSR 8Y CAGR (39.27%)
Div yield —
ROE (56.21%)
Biotechnology
Beta (5Y) 0.90
PE TTM —
TSR TTM (82.59%)
Mkt cap kr 74.51M
ROIC (34.87%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.531
(4.76%)
(77.85%)
Hold 11|11|10|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
11.56%
10.47%
15.61%
27.91%
Revenuekr M
4.337
4.263
4.138
4.115
15.92%
8.59%
6.98%
0.36%
Peers (US$7.533M)
Cap (US$)
PE
6.612M
—
Capital
TTM
5Y
10Y
Leveragex
1.628
0.146
0.123
EBIT/Intx
0.501
1.169
1.115
Own earn%
10.73
396.58
342.95
Sh yield%
36.88
23.04
24.33
Owners
Insiders/Inst%
14.08
22.28
Short interest%
5.79
SBC / revenue%
2.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
5